490 followers
True, CABG is superior to ICP in diabetic patients with multivessel disease but ICP resolves better when CABG cannot. @jaccjournals https://t.co/NghZr9G1H8 #drerwintellez #radialfirst
True, CABG is superior to ICP in diabetic patients with multivessel disease but ICP resolves better when CABG cannot. @jaccjournals https://t.co/NghZr9G1H8 #drerwintellez #radialfirst
Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary Disease. https://t.co/5BXn4doL9F
For the study: https://t.co/gjvP7qdp6u
RT @edurontoFF: .La CRM reduce 39% la mortalidad y 99% el MACE con respecto a la ATC en pacientes diabeticos con enfermedad coronaria multi…